Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eewpCfbwoceYdRBlqBxN

  ADVERTISEMENT  
January 9, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Study shows hemophilia drug reduces bleed rates by 72.5%
    A Phase III clinical trial found that Baxter International's anti-inhibitor coagulant complex treatment for hemophilia lowered bleeding rates by 72.5% in a prophylactic treatment group, the company reported. The study involved patients with hemophilia A or B. The company will use the findings in a biologics license application in this quarter. Reuters (1/8) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Clinical Research: Understanding the Methodology Toolbox
Clinical Research: Understanding the Methodology Toolbox compiles articles of evidence-based research for use as an educational resource for those involved in clinical research, healthcare professionals and trainees in transfusion medicine and other medical specialties. Now in the AABB Marketplace.

  Science & Health 
  • High court dismisses challenge to federal funding of ESC research
    The Supreme Court rejected without comment a case challenging federal funding for embryonic stem cell research. The challengers, adult stem cell researchers James Sherley and Theresa Deisher, argued that research using human embryonic stem cells was in violation of a federal law. President Barack Obama reversed an earlier ban on federal funding for embryonic stem cell research, though the initial extraction of stem cells still depends on private funds because of a law against creating or destroying embryos for research. LiveScience.com (1/7) LinkedInFacebookTwitterEmail this Story
  • Study determines risk factors for post-surgery morbidity, mortality
    An analysis of more than 240,000 cases in a national database determined seven independent preoperative risk factors that increase morbidity and mortality risk following ambulatory surgery. The factors were disseminated cancer, paraplegia or quadriplegia, age 70 or older, steroid use, kidney failure, chronic obstructive pulmonary disease and history of transient ischemic attack or stroke. Surgical site infection and intraoperative blood transfusion were among the most common complications. The findings may help improve preoperative patient screening in outpatient surgical facilities, a researcher said. Anesthesiology News (free registration) (1/2013) LinkedInFacebookTwitterEmail this Story
  • H5N1 avian influenza research may ramp up again
    A meeting with virologists from around the world to discuss avian influenza research could be an indication the U.S. may support an end to the voluntary ban on H5N1 research, provided that new work meets a number of criteria. Research was stopped after two groups developed strains of the virus that easily spread between ferrets, raising fears the virus could escape and spark a pandemic. The proposed parameters for avian influenza research agreed upon at the conference include requirements that the research be highly significant, involve manageable risks and not result in a strain that could not naturally evolve. Wired.co.uk (U.K.) (1/8) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Health care spending may be poised to accelerate, report finds
    Data from a CMS report showed U.S. spending on health care grew by 3.9% in 2011, marking the third year in a row of relatively small increases in spending. However, the report suggests spending growth may pick up in the coming years as the economy rebounds. The report appears in the journal Health Affairs. Reuters (1/7) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  Government & Regulatory 
  Association News 
  • Reminder: AABB requests nominations for 2013, 2014 memorial awards
    AABB is seeking nominations for its 2013 and 2014 memorial awards, which will honor individuals who have advanced the practice of transfusion medicine and cellular therapies. The awards are presented to recognize achievements in administration, immunohematology, quality and innovative research, and overall outstanding service. Individuals are encouraged to nominate candidates by completing and submitting the online nomination form by Jan. 25. Recipients will be honored at the 2013 AABB Annual Meeting in Denver or the 2014 AABB Annual Meeting in Philadelphia. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Director of Quality SystemsRock River Valley Blood CenterUS - IL - Rockford
Clinical Lab Specialist IICreative Testing SolutionsUS - FL - St. Petersburg
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
DIRECTOR, COMMUNITY CENTER IUnited Blood ServicesUS - NV - Reno
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Click here to view more job listings.

  SmartQuote 
If you want to test your memory, try to recall what you were worrying about one year ago today."
--E. Joseph Cossman,
American entrepreneur and inventor


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information